Prashant is available for hire
Hire PrashantPrashant Kudva
Verified Expert in Finance
Finance Expert
Location
New York, NY, United States
Toptal Member Since
April 27, 2017
Prashant has 14 years of experience as an investment banker and five years experience leading business development teams in biotech. Prashant has worked on over $50 billion of M&A and capital raises. His sector expertise includes biotech, healthcare, metals & mining, technology, and clean tech. As a freelancer, he enjoys helping companies with financial planning, valuation, capital raising, investor presentations, M&A advisory, and other financial analyses.
Career Highlights
Vice President, Business Development
EmendoBio
Head of Business Development
Generian
Education Highlights
Master's Degree
Johns Hopkins University
Bachelor's Degree
University of Chicago
Certification Highlights
FINRA Series 79
FINRA
Case Studies
Industry Expertise
Other Expertise
Work Experience
Vice President, Business Development
2023 - PRESENT
EmendoBio
- Worked on the company's 1st out-licensing transaction with a partner in Sweden.
- Led global business development for an EMEA company with Japanese investors while working in the USA.
- Managed the company's capital-raising efforts and maintained relationships with investment banks.
- Established a network of potential licensees of nuclease technology as well as a network of enabling technologies.
Focus areas: Biotechnology, Mergers & Acquisitions (M&A), Valuation, Business Development, Healthcare IT, Financing, Finance, Capital Raising, Growth Capital Raising, Licensing, Intellectual Property Licensing, Cross-border M&A, Financial Modeling, Fundraising, Market Research, Business Planning, Pitch Deck Consultant
Head of Business Development
2021 - 2023
Generian
- Contributed to the company's 1st transaction with big pharma for a number of small molecule targets.
- Co-establishing the business development and outreach functions as the 5th employee at a startup.
- Collaborated on company strategy and growth pathways for an early-stage small molecule platform company.
Focus areas: Mergers & Acquisitions (M&A), Investment Banking, Biotechnology, Business Development, Product Licensing, Valuation, M&A Valuation (DCF), Comparable Company Analysis, Financial Modeling, Fundraising, Market Research, Business Planning
Business Development | M&A
2020 - 2021
Editas
- Worked on strategy and in/out-licensing products for Editas, a leading gene-editing company.
- Maintained the database of strategic options and priorities in the gene therapy, cell therapy, and gene editing spaces.
- Worked on all aspects of mergers and acquisitions and in-licensing and out-licensing products that matched the company's goals.
Focus areas: Mergers & Acquisitions (M&A), Intellectual Property Licensing, Licensing, Fundraising, Life Science, Fundraising Consultant, Biotechnology, Product Licensing, Strategy, M&A Strategy, Financial Modeling, Market Research, Business Planning
Business Development and M&A
2019 - 2020
AMAG Pharmaceuticals
- Worked on M&A and strategic transactions including alliances, in-licensing assets, and out-licensing assets, acquisitions and divestitures.
- Built financial and market models in valuing and evaluating potential targets.
- Focused on multiple biotech therapeutic areas including women's health and hematology segments.
- Led cross-functional teams in M&A transactions ensuring internal and external alignment on deal goals and objectives.
- Handled transaction negotiation, deal valuation, seeking and evaluating new acquisition opportunities and presenting potential opportunities to the executive team and board.
Focus areas: Capital Raising, Strategy, Business Development, Valuation, Financial Planning & Analysis (FP&A), Financing, Women's Health, Biotechnology, Mergers & Acquisitions (M&A), Life Science, Financial Modeling, Pitch Decks, Market Research, Business Planning, Pitch Deck Consultant
Vice President and Director (Healthcare Group)
2011 - 2016
Stifel
- Advised companies in the healthcare industry on capital raises (IPOs, private rounds, and public follow-on) and M&A transactions.
- Assisted companies with FP&A, investor decks, valuation analyses, and positioning.
- Worked with companies to identify assets or companies to acquire or assets to divest.
- Supported drafting of SEC filings for companies in transactions, including in over six IPOs.
- Helped companies analyze capital structure and long-term business plan goals by analyzing various financial ratios and trends.
- Worked as a group staffer and managed a team of 12 analysts and associates.
Focus areas: Corporate Finance, Discounted Cash Flow (DCF), Comparable Company Analysis, Investor Presentations, Business Planning, Financial Planning & Analysis (FP&A), Growth Capital Raising, Capital Raising, Financial Modeling, Valuation, Investment Banking, Healthcare, Biotechnology, Mergers & Acquisitions (M&A), Life Science, Venture Capital, Fundraising Consultant, Pitch Decks, Fundraising, Market Research, Pitch Deck Consultant
Associate Director
2009 - 2011
Standard Chartered
- Worked on cross-border M&A deals between the U.S. and Asia/Europe.
- Identified potential targets for U.S. companies in Asia/Europe and vice versa.
- Conducted valuation, M&A modeling, and other analyses of the complex issues that can arise during a cross-border merger.
- Assisted clients in meetings and presented the issues that can arise in cross-border mergers.
- Served as a founding member of the team that set up the necessary infrastructure and base modeling templates.
- Performed accretion/dilution analyses for companies looking to raise capital to understand optimal capital structure.
- Developed IRR analysis to view potential LBO returns on transactions.
Focus areas: Corporate Finance, Sovereign Wealth Funds (SWFs), Private Company Valuation, Comparable Company Analysis, Budgeting, Financial Modeling, Metals & Mining, Valuation Multiples, Valuation, Valuation Modeling, Capital Raising, Financial Planning & Analysis (FP&A), Strategy, Investment Memoranda, Mergers & Acquisitions (M&A), Cross-border M&A, Venture Capital, Fundraising Consultant, Pitch Decks, Market Research, Pitch Deck Consultant
Senior Analyst
2007 - 2009
Lazard Freres
- Worked on building Lazard's levelized cost of energy (LCOE) analysis.
- Built various models, including LBO models for companies of various sizes during M&A transactions in the clean tech and TMT spaces.
- Conducted various financial analyses and helped emerging solar companies with their budgeting and FP&A efforts.
- Modeled complex solar and wind farms that included complex PTC and ITCs.
- Aided companies in compiling investor presentations and models for M&A deals.
- Performed accretion/dilution analyses for companies looking to raise capital to understand optimal capital structure.
Focus areas: Corporate Finance, TMT, SaaS, Renewable Energy, CleanTech, Investor Presentations, Pitch Decks, Financial Planning & Analysis (FP&A), Strategy, Financial Modeling, Valuation, Mergers & Acquisitions (M&A), Venture Capital, Fundraising Consultant, Market Research, Pitch Deck Consultant
Financial Analyst
2006 - 2007
Merrill Lynch
- Collaborated with Merrill Lynch's TMT corporate finance group to implement capital raises and M&A transactions.
- Worked on debt structuring complex transactions, including convertibles with bond hedges.
- Built financial models for company valuation, including LBO analysis and returns on debt/equity.
- Performed accretion/dilution analyses for companies looking to raise capital to understand optimal capital structure.
Focus areas: Transaction Comparables, Comparable Company Analysis, Convertible Debt, Transaction Modeling, TMT, Corporate Finance, Mergers & Acquisitions (M&A), Venture Capital, Fundraising Consultant, Financial Modeling, Pitch Decks, Market Research, Pitch Deck Consultant
Education
2018 - 2020
Master's Degree in Biotechnology Enterprise and Entrepreneurship
Johns Hopkins University - Baltimore, MD
2001 - 2005
Bachelor's Degree in Economics and Political Science
University of Chicago - Chicago, IL, USA
Certifications
JULY 2009 - PRESENT
FINRA Series 79
FINRA
Collaboration That Works
How to Work with Toptal
Toptal matches you directly with global industry experts from our network in hours—not weeks or months.
1
Share your needs
Discuss your requirements and refine your scope in a call with a Toptal domain expert.
2
Choose your talent
Get a short list of expertly matched talent within 24 hours to review, interview, and choose from.
3
Start your risk-free talent trial
Work with your chosen talent on a trial basis for up to two weeks. Pay only if you decide to hire them.
Top talent is in high demand.
Start hiring